Neogen Corporation (NEOG) - Total Assets
Based on the latest financial reports, Neogen Corporation (NEOG) holds total assets worth $3.35 Billion USD as of May 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Neogen Corporation - Total Assets Trend (1988–2026)
This chart illustrates how Neogen Corporation's total assets have evolved over time, based on quarterly financial data. Also see NEOG market cap overview for the company's overall valuation and market capitalisation.
Neogen Corporation - Asset Composition Analysis
Current Asset Composition (May 2026)
Neogen Corporation's total assets of $3.35 Billion consist of 18.1% current assets and 81.9% non-current assets. Review Neogen Corporation debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.5% |
| Accounts Receivable | $146.80 Million | 4.4% |
| Inventory | $144.30 Million | 4.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.32 Billion | 39.4% |
| Goodwill | $1.05 Billion | 31.3% |
Asset Composition Trend (1988–2026)
This chart illustrates how Neogen Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Neogen Corporation (NEOG) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neogen Corporation's current assets represent 18.1% of total assets in 2026, a decrease from 71.2% in 1988.
- Cash Position: Cash and equivalents constituted 5.5% of total assets in 2026, down from 21.2% in 1988.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 70.0% of total assets, an increase from 1.0% in 1988.
- Asset Diversification: The largest asset category is intangible assets at 39.4% of total assets.
Neogen Corporation Competitors by Total Assets
Key competitors of Neogen Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
TransMedics Group Inc
NASDAQ:TMDX
|
USA | $1.46 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
|
China | CN¥2.70 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
Neogen Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.82 | 3.32 | 12.00 |
| Quick Ratio | 2.91 | 2.22 | 9.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $446.40 Million | $402.93 Million | $558.36 Million |
Neogen Corporation - Advanced Valuation Insights
This section examines the relationship between Neogen Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.24 |
| Latest Market Cap to Assets Ratio | 0.78 |
| Asset Growth Rate (YoY) | -2.8% |
| Total Assets | $3.35 Billion |
| Market Capitalization | $2.60 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Neogen Corporation's assets below their book value (0.78x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Neogen Corporation's assets decreased by 2.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Neogen Corporation (1988–2026)
The table below shows the annual total assets of Neogen Corporation from 1988 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-05-31 | $3.35 Billion | -2.84% |
| 2025-05-31 | $3.44 Billion | -24.29% |
| 2024-05-31 | $4.55 Billion | -0.12% |
| 2023-05-31 | $4.55 Billion | +358.69% |
| 2022-05-31 | $992.93 Million | +7.90% |
| 2021-05-31 | $920.19 Million | +15.43% |
| 2020-05-31 | $797.18 Million | +14.58% |
| 2019-05-31 | $695.74 Million | +12.58% |
| 2018-05-31 | $618.01 Million | +16.96% |
| 2017-05-31 | $528.41 Million | +16.98% |
| 2016-05-31 | $451.71 Million | +15.18% |
| 2015-05-31 | $392.18 Million | +13.58% |
| 2014-05-31 | $345.30 Million | +19.38% |
| 2013-05-31 | $289.25 Million | +14.96% |
| 2012-05-31 | $251.60 Million | +14.54% |
| 2011-05-31 | $219.66 Million | +21.88% |
| 2010-05-31 | $180.23 Million | +26.77% |
| 2009-05-31 | $142.18 Million | +12.52% |
| 2008-05-31 | $126.36 Million | +20.02% |
| 2007-05-31 | $105.28 Million | +19.25% |
| 2006-05-31 | $88.29 Million | +38.20% |
| 2005-05-31 | $63.88 Million | +6.52% |
| 2004-05-31 | $59.98 Million | +24.85% |
| 2003-05-31 | $48.04 Million | +20.38% |
| 2002-05-31 | $39.90 Million | +20.84% |
| 2001-05-31 | $33.02 Million | +11.83% |
| 2000-05-31 | $29.53 Million | +13.13% |
| 1999-05-31 | $26.10 Million | +2.76% |
| 1998-05-31 | $25.40 Million | +9.96% |
| 1997-05-31 | $23.10 Million | +100.87% |
| 1996-05-31 | $11.50 Million | 0.00% |
| 1995-05-31 | $11.50 Million | +26.37% |
| 1994-05-31 | $9.10 Million | +24.66% |
| 1993-05-31 | $7.30 Million | -3.95% |
| 1992-05-31 | $7.60 Million | -10.59% |
| 1991-05-31 | $8.50 Million | -9.57% |
| 1990-05-31 | $9.40 Million | +104.35% |
| 1989-05-31 | $4.60 Million | -11.54% |
| 1988-05-31 | $5.20 Million | -- |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage … Read more